Abstract
To determine if histopathology of the sinus mucosa predicts symptomatic outcomes after endoscopic sinus surgery (ESS). The histopathology of the sinus mucosa and preoperative and postoperative symptom scores from the Rhinosinusitis Symptom Inventory (RSI) for adults undergoing ESS for chronic rhinosinusitis (CRS) without polyposis were reviewed. Linear regression analysis was conducted to examine the relationship between tissue pathology inflammatory severity score and the postoperative RSI symptom scores, adjusting for baseline RSI scores, Lund score, postoperative topical steroid, antihistamine, and antibiotic use. A total of 112 patients were enrolled (average age, 41.2 years; 68.8% female) with a follow-up of 19.1 ± 8.7 months (mean ± standard deviation [SD]). Mean preoperative and postoperative RSI domain scores for nasal symptoms and total symptoms were (52.4, 21.4) and (41.2, 17.7), respectively (p < 0.001). Topical steroid utilization increased from 15.3 to 20.7 weeks (p = 0.086) whereas antihistamine use and antibiotic use decreased by 1.4 and 1.6 weeks, respectively (p = 0.594 and 0.092). Pathology severity score did not significantly predict postoperative symptom scores on any of the RSI symptom domains nor the total symptom score (all p > 0.05). Although pathologic inflammation of the paranasal sinuses is inherent to CRS, increasing pathology severity at ESS does not predict poorer symptomatic outcomes after ESS.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.